NO983955D0 - Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler - Google Patents

Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler

Info

Publication number
NO983955D0
NO983955D0 NO983955A NO983955A NO983955D0 NO 983955 D0 NO983955 D0 NO 983955D0 NO 983955 A NO983955 A NO 983955A NO 983955 A NO983955 A NO 983955A NO 983955 D0 NO983955 D0 NO 983955D0
Authority
NO
Norway
Prior art keywords
pharmaceuticals
preparation
erythromycin derivatives
new erythromycin
new
Prior art date
Application number
NO983955A
Other languages
English (en)
Other versions
NO983955L (no
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983955D0 publication Critical patent/NO983955D0/no
Publication of NO983955L publication Critical patent/NO983955L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO983955A 1996-02-28 1998-08-27 Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler NO983955L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
NO983955D0 true NO983955D0 (no) 1998-08-27
NO983955L NO983955L (no) 1998-08-27

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983955A NO983955L (no) 1996-02-28 1998-08-27 Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler

Country Status (31)

Country Link
US (1) US6096714A (no)
EP (1) EP0885234B1 (no)
JP (1) JP4102440B2 (no)
KR (1) KR100486053B1 (no)
CN (1) CN1168734C (no)
AP (1) AP952A (no)
AR (1) AR005999A1 (no)
AT (1) ATE217633T1 (no)
AU (1) AU716204B2 (no)
BG (1) BG63207B1 (no)
BR (1) BR9707709B1 (no)
CZ (1) CZ293893B6 (no)
DE (1) DE69712610T2 (no)
DK (1) DK0885234T3 (no)
EA (1) EA001376B1 (no)
EE (1) EE9800265A (no)
ES (1) ES2176698T3 (no)
FR (1) FR2745290B1 (no)
HU (1) HU227567B1 (no)
IL (1) IL125622A (no)
NO (1) NO983955L (no)
NZ (1) NZ331600A (no)
OA (1) OA10845A (no)
PL (1) PL191736B1 (no)
PT (1) PT885234E (no)
SK (1) SK118498A3 (no)
TR (1) TR199801713T2 (no)
UA (1) UA58504C2 (no)
WO (1) WO1997031929A1 (no)
YU (1) YU37098A (no)
ZA (1) ZA971659B (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
JP2003527301A (ja) * 1997-10-29 2003-09-16 大正製薬株式会社 エリスロマイシンａ誘導体
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
ID30233A (id) 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010879A1 (en) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183700A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
EP2214484A4 (en) * 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
US8796232B2 (en) * 2008-10-24 2014-08-05 Cempra Pharmaceuticals, Inc. Methods for treating resistant diseases using triazole containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
CN103080122A (zh) 2010-03-22 2013-05-01 森普拉制药公司 大环内脂的结晶形式及其用途
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
YU37098A (sh) 1999-07-28
AR005999A1 (es) 1999-07-21
IL125622A0 (en) 1999-04-11
DE69712610D1 (de) 2002-06-20
WO1997031929A1 (fr) 1997-09-04
EA199800768A1 (ru) 1999-02-25
AU1929897A (en) 1997-09-16
CN1168734C (zh) 2004-09-29
DK0885234T3 (da) 2002-08-26
PL191736B1 (pl) 2006-06-30
AP952A (en) 2001-03-29
BR9707709B1 (pt) 2014-10-14
ATE217633T1 (de) 2002-06-15
OA10845A (fr) 2003-02-05
HUP9902576A1 (hu) 1999-12-28
HUP9902576A3 (en) 2001-03-28
FR2745290B1 (fr) 1998-04-03
ZA971659B (en) 1998-02-26
HU227567B1 (en) 2011-08-29
BG63207B1 (bg) 2001-06-29
EE9800265A (et) 1999-02-15
US6096714A (en) 2000-08-01
AU716204B2 (en) 2000-02-24
PL328608A1 (en) 1999-02-01
NZ331600A (en) 1999-08-30
CZ293893B6 (cs) 2004-08-18
EP0885234A1 (fr) 1998-12-23
FR2745290A1 (fr) 1997-08-29
EA001376B1 (ru) 2001-02-26
KR19990087324A (ko) 1999-12-27
EP0885234B1 (fr) 2002-05-15
BG102691A (en) 1999-06-30
SK118498A3 (en) 1999-07-12
CZ258798A3 (cs) 1998-12-16
PT885234E (pt) 2002-10-31
TR199801713T2 (xx) 1998-12-21
JP4102440B2 (ja) 2008-06-18
BR9707709A (pt) 1999-04-06
CN1212700A (zh) 1999-03-31
ES2176698T3 (es) 2002-12-01
IL125622A (en) 2003-10-31
NO983955L (no) 1998-08-27
KR100486053B1 (ko) 2005-06-16
UA58504C2 (uk) 2003-08-15
AP9801318A0 (en) 1998-09-30
JP2000505469A (ja) 2000-05-09
DE69712610T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
NO983955D0 (no) Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler
NO964654D0 (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
NO954942L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
NO20012272L (no) Nye erythromycinderivater, fremstillingsmetode og anvendelse som medisiner
NO981053D0 (no) Nye 5-O-deoaminyl-6-O-metylerytronolid A-derivater, metode for fremstilling av disse og anvendelse derav for fremstilling av biologisk aktive produkter
NO974685D0 (no) Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DK1006110T3 (da) Derivater af acylpiperazinylpyrimidiner, fremstilling deraf og anvendelse som lægemidler
NO995745L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse, samt deres anvendelse som medikamenter
DK1015421T3 (da) Nye phenylamidinderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler
NO992859L (no) Nye derivater av erytromycin, fremgangsmÕte for fremstilling av disse og deres anvendelse som medikamenter
DK0907633T3 (da) Nye syntetiske catecholderivater, fremgangsmåde til fremstilling og anvendelse deraf
DK0931088T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
NO980324L (no) Didepsipeptidbaserte endoparasitticider, nye didepsipeptider og fremgangsmåte for fremstilling av disse
DK0946580T3 (da) Nye erythromycinforbindelser, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
NO963129L (no) Nye leukotrien-B4-derivater, fremgangsmåte for fremstilling derav og anvendelse derav som legemidler
NO20006573L (no) Nye 17-halogenerte 19-nor-steroider, metode og mellomprodukter for fremstilling av disse, anvendelse som medisiner og farmasöytiske preparater inneholdende disse
NO995905D0 (no) Nye fencyclidinderivater, fremgangsmåter for fremstilling og farmasöytiske blandinger som inneholder disse
NO991481L (no) Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse
NO991482L (no) Nye fenoksyethylaminderivater, fremgangsmÕte for fremstilling, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application